SCHEMBL2588026

SCHEMBL2588026

O=[N+]([O-])c1cccc(SO)c1[N+](=O)[O-]

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 2/20 0.58
TSHR P16473 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.47
PDE7A Q13946 2/20 0.47
TDP1 Q9NUW8 4/20 0.47
ALDH1A1 P00352 3/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
ERN1 O75460 1/20 0.41
S100A4 P26447 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HSD17B10 Q99714 1/20 0.39
TXNRD1 Q16881 1/20 0.39
TXNRD3 Q86VQ6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2588027 1.00 GPR35 (0.58) GPR35TSHRSMN1; SMN2PDE7ATDP1
SCHEMBL6930370 0.84 PDE7A (0.59) GPR35TSHRSMN1; SMN2PDE7ATDP1
SCHEMBL3192750 0.84 GPR35 (0.57) GPR35TSHRSMN1; SMN2PDE7ATDP1
SCHEMBL6860656 0.82 PDE7A (0.56) GPR35SMN1; SMN2PDE7ATDP1ALDH1A1
SCHEMBL2458682 0.82 PDE7A (0.56) GPR35SMN1; SMN2PDE7ATDP1ALDH1A1
SCHEMBL3192742 0.81 GPR35 (0.53) GPR35TSHRSMN1; SMN2PDE7ATDP1
SCHEMBL2009807 0.81 GPR35 (0.53) GPR35TSHRSMN1; SMN2PDE7ATDP1
SCHEMBL944057 0.81 TSHR (0.53) GPR35TSHRSMN1; SMN2PDE7ATDP1
Hydrochloric Acid SCHEMBL10637432 0.80 PDE7A (0.55) GPR35SMN1; SMN2PDE7ATDP1ALDH1A1
SCHEMBL6930373 0.79 GPR35 (0.52) GPR35TSHRSMN1; SMN2PDE7ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151895-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2025-07-17 WO disclosed
EP-3775203-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF Wave Life Sciences Ltd. (SG) 2021-02-17 EP disclosed
WO-2019200185-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF WAVE LIFE SCIENCES LTD. (SG) 2019-10-17 WO disclosed
CN-105492460-A Stabilized polypeptide insulin receptor modulators HARVARD COLLEGE 2016-04-13 CN disclosed
CN-105338812-A Benzimidazole derivatives and uses thereof WHITEHEAD BIOMEDICAL INST 2016-02-17 CN disclosed
CN-104936595-A Methods and compositions for locally increasing body fat TOPOKINE THERAPEUTICS INC 2015-09-23 CN disclosed
US-8586020-B2 Poly(organophosphazene) composition for biomaterials KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2013-11-19 US disclosed
WO-2011134067-A1 NOVEL AMINO ACID MOLECULE AND USES THEREOF 6570763 CANADA INC. (CA) 2011-11-03 WO disclosed
WO-2009067541-A2 INTEGRASE INHIBITORS GILEAD SCIENCES, INC. (US) 2009-05-28 WO disclosed
WO-2008005542-A2 ANTIVIRAL PHOSPHINATE COMPOUNDS GILEAD SCIENCES, INC., (US) 2008-01-10 WO disclosed
CN-1321641-C Method for treating allergies using substituted pyrazoles ORTHO MCNEIL PHARM INC (US) 2007-06-20 CN disclosed
CN-1505509-A Method for treating allergies using substituted pyrazoles ����-������ҩƷ��˾ 2004-06-16 CN disclosed
EP-0807118-A2 NOVEL COMPOUNDS AND METHODS FOR MAKING AND USING SAME GILEAD SCIENCES, INC. (US) 1997-11-19 EP disclosed
WO-1996023801-A2 NOVEL COMPOUNDS AND METHODS FOR MAKING AND USING SAME GILEAD SCIENCES, INC. (US) 1996-08-08 WO disclosed